issued from China Food and Drug Administration (CFDA) at the beginning of 2018 as the Company had to redesign its packaging to comply with the requirements of the license and adjust its sales structures
(Unit : Million Baht) 30 September 2016 31 December 2016 Change Current assets 869.95 893.90 (23.95) Non-current assets 1,262.26 1,203.81 58.45 Total assets 2,132.21 2,097.71 34.50 Current liabilities
– 2018 Balance by Quarter Change Q3–18 Q2–18 Q3–17 Q3–18 VS Q2–18 Q3–18 VS Q3–17 (Million Baht: MB) (MB) % (MB) % Total Revenue 1,053.3 1,029.9 1,633.1 23.4 2.3 (579.8) (35.5) Total Operating Expenses
in order to increase sales, in the meantime focus on control system and reduce expenses to conform actual incomes which decreased. Performance Analysis Unit : MB For the quarterly Change For the six
due to temporary closure of 11 branches since March 22, 2020 in order to comply with regulation issued under The Emergency Decree on Public Administration in Emergency Situations. Performance Analysis
our new and existing customers. Unit : million Baht Jan - Sept 2020 % Jan - Sept 2019 % Change %YoY Sales and Services Revenues 382.82 99.4 250.79 99.6 132.03 52.6 Other income 2.33 0.6 0.94 0.4 1.39
administration expenses was Baht 15.43 million compare with the same period of previous year amount to Baht 13.93 million, increase by Baht 1.50 million or increase 10.75%, due to the company paid for financial
10.69% (189.69) (88.71%) 31 December 2019 31 December 2018 Change For the year ended Page 2 Revenue from Sale of real estate Revenue from sale of real estate for the year ended 31 December 2019 and 2018
1: Overall Financial Performance Unit: million baht Jan-Mar 2019 % Jan-Mar 2020 % Change % YoY Revenue 132.54 100.0% 179.21 100.0% 46.67 35.2% Cost (73.41) (55.4%) (93.71) (52.3%) (20.30) 27.7% Gross
Administration (CFDA) at the beginning of 2 0 1 8 as the Company had to redesign its packaging to comply with the requirements of the license. Furthermore, the Company also found it necessary to adjust its sales